Toggle navigation
Home
People
Departments
Research
About
Login
Search
PREVENT GU: Prevention of thromboembolism with rivaroxaban in GU cancer patients receiving chemotherapy: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
Grant
Overview
Affiliation
View All
Overview
date/time interval
April 1, 2023 - March 31, 2026
awarded by
Canadian Institutes of Health Research
total award amount
CAD 141525
Affiliation
contributor
Hotte, Sebastien
Funded by
Lalani, Aly-Khan
Funded by